Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from CareRx ( (TSE:CRRX) ) is now available.
CareRx Corporation reported positive financial results for the third quarter of 2025, with revenue increasing to $93.2 million and adjusted EBITDA rising to $8.3 million. The company also initiated a quarterly dividend and renewed its share buyback program, reflecting confidence in its strategic positioning and commitment to delivering long-term value to stakeholders. Notable events included hosting Ontario’s Minister of Long-Term Care to showcase their innovative services and declaring a dividend of $0.02 per common share.
The most recent analyst rating on (TSE:CRRX) stock is a Buy with a C$4.25 price target. To see the full list of analyst forecasts on CareRx stock, see the TSE:CRRX Stock Forecast page.
Spark’s Take on TSE:CRRX Stock
According to Spark, TipRanks’ AI Analyst, TSE:CRRX is a Neutral.
CareRx’s overall stock score reflects significant financial performance challenges, particularly with declining revenues and negative profitability metrics. Despite some technical indicators showing bullish momentum, the valuation remains concerning due to a negative P/E ratio. The lack of earnings call data and corporate events further limits the assessment of future prospects.
To see Spark’s full report on TSE:CRRX stock, click here.
More about CareRx
CareRx Corporation is Canada’s leading provider of pharmacy services, specializing in serving seniors living and other congregate care communities. The company focuses on delivering integrated pharmacy services and personalized medication management to enhance clinical support for its clients.
Average Trading Volume: 45,665
Technical Sentiment Signal: Buy
Current Market Cap: C$225.9M
Learn more about CRRX stock on TipRanks’ Stock Analysis page.